堅寶國際(00675.HK)預計上半年純利同比增長約110%
格隆匯7月29日丨堅寶國際(00675.HK)公佈,預期公司截至2021年6月30日止六個月的公司擁有人所佔的未經審核綜合溢利將錄得大幅增長約110%(與截至2020年6月30日止六個月比較)。
公司擁有人所佔的未經審核綜合溢利增長(與上年同期比較)主要由於:(i)與上年同期集團業務受COVID-19疫情影響時相比,銷售訂單有所增加;(ii)生產效率提高,受惠於一個客户採購相同產品的訂單;上述銷售增長對集團財務表現的影響部分被集團的銷售成本增加所抵消(主要由於集團製造過程中使用的原材料價格上升)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.